Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 11

1.

Periventricular white matter hyperintensities increase the likelihood of progression from amnestic mild cognitive impairment to dementia.

van Straaten EC, Harvey D, Scheltens P, Barkhof F, Petersen RC, Thal LJ, Jack CR Jr, DeCarli C; Alzheimer's Disease Cooperative Study Group..

J Neurol. 2008 Sep;255(9):1302-8. doi: 10.1007/s00415-008-0874-y. Epub 2008 Sep 25.

2.

Donepezil for mild and moderate Alzheimer's disease.

Birks J S, Melzer D.

Cochrane Database Syst Rev. 2000;(2):CD001190. Review. Update in: Cochrane Database Syst Rev. 2000;(4):CD001190.

PMID:
10796620
3.

Donepezil for dementia due to Alzheimer's disease.

Birks J, Harvey RJ.

Cochrane Database Syst Rev. 2006 Jan 25;(1):CD001190. Review.

PMID:
16437430
4.

Cholinesterase inhibitors for dementia with Lewy bodies, Parkinson's disease dementia and cognitive impairment in Parkinson's disease.

Rolinski M, Fox C, Maidment I, McShane R.

Cochrane Database Syst Rev. 2012 Mar 14;(3):CD006504. doi: 10.1002/14651858.CD006504.pub2. Review.

PMID:
22419314
5.

Vitamin E for Alzheimer's disease and mild cognitive impairment.

Isaac MG, Quinn R, Tabet N.

Cochrane Database Syst Rev. 2008 Jul 16;(3):CD002854. doi: 10.1002/14651858.CD002854.pub2. Review. Update in: Cochrane Database Syst Rev. 2012;11:CD002854.

PMID:
18646084
6.

Donepezil for dementia due to Alzheimer's disease.

Birks JS, Harvey R.

Cochrane Database Syst Rev. 2003;(3):CD001190. Review. Update in: Cochrane Database Syst Rev. 2006;(1):CD001190.

PMID:
12917900
7.

Current concepts of analysis of cerebral white matter hyperintensities on magnetic resonance imaging.

Yoshita M, Fletcher E, DeCarli C.

Top Magn Reson Imaging. 2005 Dec;16(6):399-407. Review.

8.

Contemplating Alzheimer's disease and the contribution of white matter hyperintensities.

Brickman AM.

Curr Neurol Neurosci Rep. 2013 Dec;13(12):415. doi: 10.1007/s11910-013-0415-7. Review.

9.

Cerebral white matter hyperintensities in the prediction of cognitive decline and incident dementia.

Mortamais M, Artero S, Ritchie K.

Int Rev Psychiatry. 2013 Dec;25(6):686-98. doi: 10.3109/09540261.2013.838151. Review.

10.

Alzheimer's Disease Risk and Progression: The Role of Nutritional Supplements and their Effect on Drug Therapy Outcome.

Giulietti A, Vignini A, Nanetti L, Mazzanti L, Di Primio R, Salvolini E.

Curr Neuropharmacol. 2016;14(2):177-90. Review.

11.

Imaging biomarkers of dementia: recommended visual rating scales with teaching cases.

Wahlund LO, Westman E, van Westen D, Wallin A, Shams S, Cavallin L, Larsson EM; From the Imaging Cognitive Impairment Network (ICINET)..

Insights Imaging. 2017 Feb;8(1):79-90. doi: 10.1007/s13244-016-0521-6. Epub 2016 Dec 21. Review.

Supplemental Content

Support Center